VolitionRx Limited (VNRX)
NYSE · Healthcare
VolitionRx Limited Operating Income 2011–2025
VolitionRx Limited annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- VolitionRx Limited operating income for the quarter ending March 31, 2026 was -5.3 M, a 3.13% decrease year-over-year.
- VolitionRx Limited operating income for the twelve months ending March 31, 2026 was -22.3 M, a 25.51% decrease year-over-year.
- VolitionRx Limited annual operating income for 2025 was -21.7 M, a 19.56% decrease from 2024.
- VolitionRx Limited annual operating income for 2024 was -27.0 M, a 24.90% decrease from 2023.
- VolitionRx Limited annual operating income for 2023 was -36.0 M, a 13.24% increase from 2022.
- VolitionRx Limited annual operating income for 2022 was -31.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
VolitionRx Limited Operating Income — FAQ
VolitionRx Limited (VNRX) operating income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is VolitionRx Limited's operating income?
VolitionRx Limited (VNRX) reported operating income of -$22M for fiscal 2025.
Where can I see VNRX's operating income history?
The chart and table above show VolitionRx Limited's operating income by year and by quarter, including the growth rate.